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ABSTRACT
Population studies such as NHANES analyze large numbers of lab-
oratory measurements and are often performed in different laborato-
ries using different measurement procedures and over an extended
period of time. Correct clinical and epidemiologic interpretations
of the results depend on the accuracy of those measurements. Unfor-
tunately, considerable variability has been observed among assays
for folate, vitamin B-12, and related biomarkers. In the past few dec-
ades, the science of metrology has advanced considerably, with the
development of improved primary reference measurement proce-
duresandhigh-level reference materials, which canserveasthe basis
for accurate measurement. A rigorous approach has been established
for making ﬁeld methods traceable to the highest-level reference
measurement procedures and reference materials. This article
reviewssomebasicprinciplesofmetrologyanddescribestheirrecent
application to measurements of folate and vitamin B-12. Am J
Clin Nutr doi: 10.3945/ajcn.111.013359.
INTRODUCTION
As detailed elsewhere in this supplement issue, variability in
laboratory measurement procedures has been a major challenge
in assessing nutritional status for folate and vitamin B-12 (1–3).
Similar problems have existed throughout laboratory medicine,
but over the last few decades improved analytic technologies,
along with international agreements on improved approaches
to test standardization, have increased the accuracy of clinical
laboratory tests. Modern concepts of measurement accuracy and
standardization are unfamiliar to many health scientists, yet they
are now recognized as essential for good patient care as well as
for research and epidemiologic applications (4). A recent expert
panel review of serum 25-hydroxyvitamin D measurements high-
lightedtheimportance of theseconcepts fornutrition applications
(5). The purpose of the current article is to brieﬂy review these
concepts in the context of vitamin B-12 and folate assessment.
MEASUREMENT STANDARDS, ORGANIZATIONS, AND
GUIDELINES
Advances in measurement science, or metrology, depend on
achieving international consensus on best practices. One fun-
damental requirement is a consistent set of measurement units.
The International Bureau of Weights and Measures (BIPM) has
maintained the primary measurement standards for the Inter-
national System of Units (SI) since 1875. The SI continues to
evolve to provide the most precise and universal unit deﬁnitions.
The important SI units for clinical laboratory measurements are
those for time (second, deﬁned relative to the cesium clock),
length (meter, deﬁned in terms of the speed of light in a vacuum
and the second), mass (kilogram, currently still deﬁned based on
a material object), and amount of substance (mole, currently
deﬁned as the number of atoms in 0.012 kg of carbon 12). The
conventional unit of volume for clinical laboratory measure-
ments is the liter, which is deﬁned as 1/1000th of a cubic meter.
New international agreements on metrology come mainly
through the Geneva-based International Organization for Stan-
dardization (ISO), a federation of 163 national standards or-
ganizations. In 1984 the ISO worked with the BIPM and 2 other
international organizations to codify a standard International
Vocabulary of Metrology (VIM). The VIM is important because
manycommontermssuchasquantity,accuracy,precision,andso
forth, have been used with a variety of meanings, causing confu-
sion(6).TheoriginalVIMwasdirectedmainlytowardindustrial-
type measurements. It has recently been revised, with input from
theInternationalFederationofClinicalChemistryandLaboratory
Medicine, to include terms more relevant to clinical laboratory
measurements. The current VIM third edition is freely available
on the BIPM website (7). ISO Technical Committee 212 also
producedawrittenstandard(17511:2003),speciﬁcallydirectedto
theclinicallaboratorycommunitythatincorporatedandextended
the concepts of VIM (8). Deﬁnitions of terms below that are in
quotations are from the VIM third edition unless otherwise in-
dicated. Another important document produced by BIPM and
other organizations, titled Guide to the Expression of Uncertainty
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measure and express the inherent error in a measurement. All
measurements have some uncertainty, and an estimate of un-
certainty should be available to assess the reliability of any mea-
surement result.
National metrology institutes, such as the National Institute of
Standards and Technology (NIST; formerly the National Bureau
of Standards) in the United States, are generally charged with
producingreferencematerialsandprovidingthehighestavailable
level of reference measurement procedures. The ISO coordinates
these standardization activities. In the United States, various
governmental agencies such as the US Food and Drug Admin-
istration, and nongovernmental organizations such as the Clinical
and Laboratory Standards Institute (CLSI), publish numerous
consensus guidelines that have broad international reach, in-
cluding some with direct relevance to metrology, such as CLSI
C53-A on commutable reference materials (10). The Expert
Committee on Biological Standardization of the World Health
Organization (WHO) also provides international reference prep-
arations for a variety of biological measurands (substances being
measured), mainly complex biological substances (eg, proteins
and hormones) that often have their measured values assigned an
activity in International Units rather than a substance concentra-
tion in SI units (ie, moles per liter).
Much of the international effort to improve the accuracy of
clinical laboratory results revolves around the concept of trac-
eability, which is described in detail in ISO International Stan-
dard 17511:2003, and which has been reviewed in depth by
Vesper and Thienpont (4). Approximately 10 y ago, the BIPM
partnered with the International Federation of Clinical Chem-
istry and Laboratory Medicine and the International Laboratory
Accreditation Cooperation to establish the Joint Committee for
Traceability in Laboratory Medicine (JCTLM) for measure-
ments made in clinical laboratories. This committee maintains
a database of higher-order reference materials and reference mea-
surement procedures that is also available on the BIPM website
(http://www.bipm.org/jctlm). We describe traceability and related
concepts below and discuss them in the context of folate and
vitamin B-12 assessments.
BASIC DEFINITIONS AND PROCEDURES
Measurand
Ameasurandisdeﬁnedas“thequantityintendedtobemeasured.”
Unfortunately, many measurement procedures do not measure only
whattheuserintends,andexactlywhattheuserintendstomeasureis
at times ambiguous, especially in complex biological systems with
many closely related analytes that have similar but not totally
equivalent bioactivity on a mole-per-liter basis. Every measurement
has inherent uncertainty related to the ambiguity in the deﬁnition of
the measurand: this is known as deﬁnitional uncertainty.
Accuracy
Accuracy of a measurement procedure is the closeness of the
measured value to “a true value of the measurand.” In some
clinical situations, absolute accuracy of a laboratory measure-
ment may not be essential: for example, if only a single mea-
surement procedure is used to monitor a given patient’s health
condition and reference ranges for that particular measurement
procedure are used for clinical interpretation of results. However,
most patients undergo measurement procedures at manydifferent
laboratories, often based on very different methodologic prin-
ciples, and test results are often compared with cutoffs in the
literature derived from very different measurement procedures. If
different research studies or population surveys are to be com-
pared, and in most clinical situations, accuracy of clinical lab-
oratory results becomes essential.
The “true value” is an unattainable ideal, but it may be deﬁned
operationally based on appropriate reference materials (see be-
low). It is also generally accepted that certain methods are pref-
erable to others to determine the “true value” of a measurand in
a sample. For example, competitive-binding immunoassay may
be a satisfactory analytic methodology for many clinical appli-
cations, but it is based on a single measurement that has known
susceptibility to cross-reactions, and it requires external calibra-
tion.Massspectrometricmethods,ontheotherhand,cangenerate
a great deal of molecule-speciﬁc information that increases the
conﬁdence in a measurement result. These methods also can use
internal standards labeled with stable isotopes (eg, deuterium or
carbon 13) to correct foranyloss of analytein thevarious steps of
the measurement process. The great progress in mass spectrom-
etry instrumentation over the last several years has been a major
beneﬁt in improving clinical laboratory standardization.
Precision
Any measurement procedure should faithfully reproduce its
own result, a property that may be referred to as repeatability,
reproducibility,o rprecision. Usually error follows a Gaussian
distribution, and SD (or CV) describes the measurement pro-
cedure’s precision. Note that the term accuracy in international
metrology encompasses the concepts of both the trueness and
precision of a measurement procedure. Thus, a measurement
procedure with poor precision cannot be very accurate, even if
an average of a number of measured values is extremely close to
the true value of the measurand in the sample. Alternatively, a
measurement procedure may be precise but inaccurate due to
lack of trueness (ie, the procedure is biased). As an example men-
tioned in this conference, the Bio-Rad Quanta Phase II procedure
for serum and red blood cell folate (Bio-Rad, Hercules, CA) was
found to have acceptable precision but substantial negative bias
compared with the microbiological assay (1).
Speciﬁcity and interference
A measurement procedure must also possess speciﬁcity, which
meansfreedomfrominterference.Inmetrologicalterminology,an
interferenceisaninﬂuencequantity,deﬁnedasa“quantitythat,in
a direct measurement, does not affect the quantity that is actually
measured, but affects the relation between the indication and the
measurement” (7). CLSI Standard EP7-A2 describes common
causesofinterferenceandprovidesadviceonassessinglaboratory
measurement procedures for interference (eg, hemolysis, icterus,
and lipemia)(11).Insomecases,theinterferenceisduetothebulk
compositionofaspecimenandnottooneidentiﬁablecompound—
clinical laboratorians often refer to such interference as a matrix
effect. For example, ethanol, saline, and pooled human serum
represent 3 very different matrices, and routine measurement pro-
cedures that clinical laboratories use are likely to respond very
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matrices.Muchmoresubtlematrixdifferences(eg,animalserumor
lyophilized human serum compared with fresh human serum) also
have a demonstrated effect on some laboratory measurement pro-
cedures (12). Matrix effects give rise to concerns about the com-
mutability of reference materials, which we discuss below in more
detail because it is often ignored or underappreciated as a major
hurdle to providing accurate clinical laboratory results.
Reference materials, traceability, and commutability
Reference materials are well-characterized materials that are
used as calibrators to calibrate the measurement procedure or as
trueness controls to check the accuracy of the measurement
procedure. A useful reference material ﬁrst and foremost requires
acleardeﬁnitionofthemeasurand.Thisisstraightforwardonlyin
the case of well-deﬁned, low-molecular-weight chemical sub-
stances such as cholesterol, sodium, and glucose. For these sub-
stances, primary reference materials or standards, which are
substances of known and very high (.99%) purity, have been
developed by national metrology organizations such as the NIST.
Relating routine measurements to the primary trueness stan-
dard is based, in the modern metrological approach, on a trace-
ability chain. Traceability is a “property of a measurement result
whereby the result can be related to a reference through a doc-
umented unbroken chain of calibrations, each contributing to the
measurement uncertainty” (7). A traceability chain for serum cho-
lesterol, which of the clinical measurands has one of the oldest
and most rigorous reference systems, is shown in Figure 1.A
very important aspect of the traceability chain is that reference
materials must be commutable, which means that they will be-
have similarly to authentic clinical specimens across 2m e a s u r e -
ment procedures. Lack of commutability has 2 major causes:
matrix effects, as discussed above, and nonnative analytes being
used to prepare the reference material (13). The consequences of
noncommutability, in this case due to a matrix effect on cho-
lesterol measurement caused by lyophilization of human serum,
are shown in Figure 2 (14). If the lyophilized reference material
were to be used as a calibrator without understanding the non-
commutability, the cholesterol measurements would be biased
by ’10%. Similarly, if a lyophilized material were used as an
external quality assessment or a trueness control without consid-
ering noncommutability, false conclusions as to a clinical mea-
surement procedure’s accuracy would be made. This situation
actually happened for cholesterol in the early 1990s when many
kinetic, cholesterol oxidase–based measurement procedures were
falsely classiﬁed as providing signiﬁcantly biased results. Simi-
larly, reference materials for folate have been prepared by
FIGURE 1. A traceability chain for serum cholesterol. By using this scheme, a routine measurement of serum cholesterol in a clinical laboratory has
a calibration that is ultimately tied to a solid material of high and known purity prepared by the National Institute of Standards and Technology (NIST).
Reference materials are shown on the left of the diagram and measurement procedures on the right. Each reference material is used to calibrate the next
measurement procedure down the chain (right-pointing arrows), and each measurement procedure is used to assign values to the next reference material (left-
pointing arrows). Each step has some associated uncertainty, which ideally can be speciﬁed, and so the overall measurement uncertainty increases as one
proceeds down the chain but can be estimated for the routine clinical result. For many more complex substances, including folate and vitamin B-12, a certiﬁed
solid reference material is not currently available. Folate and vitamin B-12 measurements can, however, now be made traceable to serum-based NIST
reference materials analogous to SRM (standard reference material) 1951b for cholesterol. SI, International System of Units; ID-GC/MS, isotope dilution-gas
chromatography/mass spectrometry; CDC, Centers for Disease Control and Prevention.
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main form of the vitamin normally in serum is 5-methyltetrahy-
drofolic acid (5-MTFA). This material could give very misleading
results in comparing different clinical laboratory folate measure-
ment procedures, depending on their speciﬁcity for different
forms of the vitamin. The central importance of commutability of
reference or proﬁciency testing materials in evaluating the accu-
racy of clinical laboratory testing cannot be overemphasized (13).
ISSUES WITH COMPLEX MEASURANDS
As the complexity of the substance being measured increases,
it becomes more difﬁcult to establish metrological traceability.
Proteins and other biomarkers can have many variant molecular
formsinthecirculation withdifferingbiologicalactivities.Itmay
be known which forms are important clinically, and it may not be
possible to prepare pure standards. Principles of traceability are
still applicable in a more limited fashion (4, 8). Harmonization
refers to the procedures to improve agreement among various
laboratory methods when rigorous traceability to a primary
standard cannot be achieved.
MARKERS OF FOLATE AND VITAMIN B-12 STATUS
Folate and vitamin B-12, although simpler molecules than
proteins, have characteristics that make standardization difﬁcult.
Each is a fairly complex molecule with multiple forms (“vitamers”)
present in clinical samples, foods, food supplements, and ref-
erence materials. Their concentrations in serum are low, espe-
cially for vitamin B-12, and they both bind tightly to proteins in
the circulation. For both substances, a microbiological mea-
surement procedure has been the historical standard for deﬁning
accuracy, whereas competitive binding assays are now the pre-
dominant methods in clinical laboratories. These facts create
serious problems in deﬁning the measurand and in establishing
traceability, because the former is a functional measurement and
the latter is a substance quantity measurement. Pure reference
materials are not available. Another complicating factor is that
red blood cells as well as serum and plasma have been a common
matrix for folate assays.
The good news with respect to serum folate assay is that the






1955 (16), which has been shown to be commutable with human
serum samples (17). The NIST certiﬁes this material for several
years,monitorsitsstability,andreplacesitasnecessary.Forvitamin
B-12, such methodology is more challenging because of the lower
concentrations. Investigators have made progress in harmonization
usingWHOInternationalReferenceReagent03/178,withavitamin




(3, 19). Unfortunately, despite all the work in preparing standard
reference materials and high-level reference measurement pro-
cedures, to our knowledge little has been done to investigate the
commutability of this vitamin B-12 SRM with clinical measure-
ment procedures, and without such commutability data its use as
a calibrator or trueness control can be risky in our view.
A study that was part of the College of American Pathologists
(CAP) Surveys Program shows some of the challenges in standard-
izingmeasurementsoffolateandvitaminB-12(20).Externalquality
assessmentschemes,alsocalledproﬁciencytestingprograms,suchas
the CAP Surveys, endeavor to assess the accuracy of clinical
laboratory testing by sending identical specimens to many





made from animal plasma or outdated human plasma from blood
banks, often with addition of preservatives, stabilizers, and other
additives.The materials are also often supplemented with various
analytes,possiblyincludingnonnativeformsofanalyte.Hence,the
commutabilityofPTMisgenerallyveryquestionable.A2003CAP
survey event, however, included a specimen from a fresh-frozen
human serum (FFS) pool along with traditional PTM specimens.
Investigators compared the results for 3 common measurement
procedures related to anemia: serum ferritin, serum folate, and
serumvitaminB-12.ThedispersionofresultsforferritinwithFFS
and PTM was essentially similar (the overall CVacross methods
was ’12% in each case), and individual method biases for FFS
and PTM were similar. For folate, however, the overall CV was
18% with FFS and twice as high (37%) with PTM. Furthermore,
individual method biases between FFS and PTM didnot correlate
with one another (Figure 3). For vitamin B-12, CVs were similar
forPTMandFFS(12%and13%,respectively),andtheindividual
method biases correlated only modestly (r = 0.55, P = 0.05; data
not shown). Thus, the study showed that this PTM was not
acommutablereferencematerialforeithervitaminB-12orfolate,
FIGURE 2. A cholesterol-oxidase–based clinical laboratory measurement
procedure compared with the Abell-Kendall (ALBK) reference measurement
procedure measured cholesterol concentrations using fresh human serum (d)
and lyophilized human serum (:), which in the past has often been used as
a reference material for both calibration purposes and as a “trueness control”
in proﬁciency surveys to evaluate a clinical measurement procedure’s
accuracy. Reprinted with permission from reference 14.
4S of 5S BOCK AND ECKFELDTparticularly the latter. The study did not investigate the cause of
the noncommutability, which could relate to matrix effects, ana-
lyte factors, or both, as discussed above.
CONCLUSIONS
Insummary,scientistsintheﬁeldofmetrologyhaveestablished
consensus documents that deﬁne an approach to establishing
consistent, accurate clinical laboratory test results for purposes of
patient care and epidemiologic studies. The complexity of folate
and vitamin B-12 make it difﬁcult to achieve full realization of
some of these principles. However, the modern metrological ap-
proachandnew,sophisticatedmassspectrometrictechniqueshave
improved the standardization of serum folate and vitamin B-12
assays, with expected beneﬁts for both epidemiologic studies and
patient care.
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